Key clinical point: Pediatric dermatologists are more confident keeping children on most systemic treatments during the COVID-19 pandemic.
Major finding: 97% said the COVID-19 pandemic affected their decision about whether to initiate an immunosuppressive medication.
Study details: A task force survey issued to academic pediatric dermatologists in April 2020, to which 37 (100%) responded.
Disclosures: Several coauthors disclosed financial ties to industry.
Reynolds et al. Pediatr Dermatol. 2020. doi: 10.1111/pde.14202.